Treatment of functional mitral valve regurgitation with the permanent percutaneous transvenous mitral annuloplasty system: results of the multicenter international Percutaneous Transvenous Mitral Annuloplasty System to Reduce Mitral Valve Regurgitation in Patients with Heart Failure trial.

[1]  É. Larose,et al.  Fatal late migration of viacor percutaneous transvenous mitral annuloplasty device resulting in distal coronary venous perforation. , 2013, The Canadian journal of cardiology.

[2]  S. Solomon,et al.  Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN Trial , 2012, European journal of heart failure.

[3]  O. Bertrand,et al.  Reversible circumflex coronary artery occlusion during percutaneous transvenous mitral annuloplasty with the Viacor system. , 2012, Journal of the American College of Cardiology.

[4]  T. Meinertz,et al.  Echocardiographic and clinical outcomes of MitraClip therapy in patients not amenable to surgery. , 2011, Journal of the American College of Cardiology.

[5]  M. Roffi,et al.  Fatal coronary sinus and aortic erosions following percutaneous transvenous mitral annuloplasty device. , 2011, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  Saibal Kar,et al.  Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.

[7]  Alec Vahanian,et al.  Transcatheter implantation of the MONARC coronary sinus device for mitral regurgitation: 1-year results from the EVOLUTION phase I study (Clinical Evaluation of the Edwards Lifesciences Percutaneous Mitral Annuloplasty System for the Treatment of Mitral Regurgitation). , 2011, JACC. Cardiovascular interventions.

[8]  J. Rodés‐Cabau,et al.  Percutaneous mitral valve annuloplasty for functional mitral regurgitation: acute results of the first patient treated with the Viacor permanent device and future perspectives. , 2010, Cardiovascular revascularization medicine : including molecular interventions.

[9]  Victor Mor-Avi,et al.  Serial changes in left ventricular shape following early mitral valve repair. , 2010, The American journal of cardiology.

[10]  Scott Lim,et al.  Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. , 2009, Journal of the American College of Cardiology.

[11]  P. Schauerte,et al.  Percutaneous Transvenous Mitral Annuloplasty: Initial Human Experience With a Novel Coronary Sinus Implant Device , 2009, Circulation. Cardiovascular interventions.

[12]  Jeroen J. Bax,et al.  Universal definition of myocardial infarction. , 2007 .

[13]  A. Ducharme,et al.  Percutaneous mitral valve annuloplasty for ischemic mitral regurgitation: First in man experience with a temporary implant , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[14]  James D. Thomas,et al.  Echocardiographic predictors of successful versus unsuccessful mitral valve repair in ischemic mitral regurgitation. , 2006, The American journal of cardiology.

[15]  D. Adams,et al.  Mitral Valve Repair With Carpentier-McCarthy-Adams IMR ETlogix Annuloplasty Ring for Ischemic Mitral Regurgitation: Early Echocardiographic Results From a Multi-Center Study , 2006, Circulation.

[16]  Richard B Devereux,et al.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[17]  E. Schwammenthal,et al.  Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. , 2005, Circulation.

[18]  Richard D. White,et al.  Ischemic mitral regurgitation: impact of the left ventricle and mitral valve in patients with left ventricular systolic dysfunction. , 2005, The Annals of thoracic surgery.

[19]  C. Otto,et al.  Timing of surgery in asymptomatic mitral regurgitation. , 2005, The New England journal of medicine.

[20]  M. Enriquez-Sarano,et al.  Heart Failure and Death After Myocardial Infarction in the Community: The Emerging Role of Mitral Regurgitation , 2005, Circulation.

[21]  EuroPCR.  EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. , 2005 .

[22]  C. O'connor,et al.  Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. , 2003, The American journal of cardiology.

[23]  Catherine M. Otto,et al.  Evaluation and Management of Chronic Mitral Regurgitation , 2001 .

[24]  C M Otto,et al.  Clinical practice. Evaluation and management of chronic mitral regurgitation. , 2001, The New England journal of medicine.

[25]  Jagmeet P. Singh,et al.  Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) , 1999, The American journal of cardiology.

[26]  J B Seward,et al.  Clinical outcome of mitral regurgitation due to flail leaflet. , 1996, The New England journal of medicine.

[27]  M. Enriquez-Sarano,et al.  Echocardiographic Prediction of Survival After Surgical Correction of Organic Mitral Regurgitation , 1994, Circulation.